Katja S. Kroker

Treatment with HC-070, a potent inhibitor of TRPC4 and TRPC5, leads to anxiolytic and antidepressant effects in mice

Stefan Just, Bertrand L. Chenard, Angelo Ceci et al. · PLoS ONE · 2018 · 135 citations · Full text

PDE9A inhibition rescues amyloid beta-induced deficits in synaptic plasticity and cognition

Katja S. Kroker, Chantal Mathis, Anelise Marti et al. · Neurobiology of Aging · 2014 · 63 citations

Synaptic Plasticity, Alzheimer's Disease, Beta-induced Deficits +9

Inhibition of acetylcholinesterase and phosphodiesterase-9A has differential effects on hippocampal early and late LTP

Katja S. Kroker, Georg Rast, Riccardo Giovannini et al. · Neuropharmacology · 2012 · 59 citations

Differential Effects, Alzheimer's Disease, Neurophysiology +9

Reduced cGMP levels in CSF of AD patients correlate with severity of dementia and current depression

Raphael Hesse, Ludwig Lausser, Pauline Gummert et al. · Alzheimer s Research & Therapy · 2017 · 44 citations · Full text

Inhibition of PDE2A, but not PDE9A, modulates presynaptic short‐term plasticity measured by paired‐pulse facilitation in the CA1 region of the hippocampus

Diego Fernández‐Fernández, Holger Rosenbrock, Katja S. Kroker · Synapse · 2015 · 35 citations

Synaptic Transmission, Neurotransmitter, Neurotransmission +22